Normalization of hypercortisolism is essential to reduce morbidity and mortality in patients with Cushing’s syndrome (CS). This is a retrospective analysis with the aim to assess biochemical control rates. We could show that biochemical control can be achieved in most patients with different subtypes of CS within a reasonable time frame